Natixis Advisors
MDLN

Natixis Advisors’s Medline Inc MDLN Stock Holding History

Natixis Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3M Buy
456,430
+345,341
+311% +$15.2M 0.03% 488
2025
Q4 		$4.67M Buy
+111,089
New +$4.69M 0.01% 838

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Natixis Advisors's MDLN Position: Q1 2026 in Review

Natixis Advisors increased its Medline Inc (MDLN) stake by 311% in Q1 2026, buying an estimated $15.2M and bringing the position to 456,430 shares worth $20.3M. The position accounts for 0.03% of the portfolio, ranked #488.

Natixis Advisors first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Natixis Advisors held 456,430 shares of Medline Inc worth $20.3M as of Q1 2026.
  • Natixis Advisors bought 345,341 Medline Inc shares in Q1 2026, an estimated $15.2M.
  • Medline Inc made up 0.03% of Natixis Advisors's portfolio in Q1 2026, its #488 holding.
  • Natixis Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.